NDC00074-3642-03: LEUPROLIDE ACETATE INJECTION KIT.
LEUPROLIDE ACETATE INJECTION KIT. Key specifications include usage_design: USED IN TREATMENT OF PROSTATIC CANCER, protective_storage_feature: ANTINEOPLASTIC DRUG, part_name_assigned_by_controlling_agency: LEUPROLIDE ACETATE INJECTION KIT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-310-7326, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| usage_design | USED IN TREATMENT OF PROSTATIC CANCER |
| test_capability_quantity | 1 |
| protective_storage_feature | ANTINEOPLASTIC DRUG |
| part_name_assigned_by_controlling_agency | LEUPROLIDE ACETATE INJECTION KIT |
| NSN | 6505-01-310-7326 |
| SPECIAL FEATURES | STERILE; LYOPHILIZED; FOR INTRAMUSCULAR INJECTION; 7.5 MG SINGLE DOSE VIAL OF LEUPROLIDE ACETATE SOLUTION 1; 1.5 ML AMPUL OF DILUENT 1; 3 ML DISPOSABLE SYRINGE WITH 22 GAGE 1 1/2 INCH NEEDLE 1; INDIVIDUALLY SEALED FOIL WRAPPED ALCOHOL WIPES 2 IN |
| PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG |
| TEST CAPABILITY QUANTITY | 1 |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | LEUPROLIDE ACETATE INJECTION KIT |
| USAGE DESIGN | USED IN TREATMENT OF PROSTATIC CANCER |
No substitute or cross-reference records for this part.